Fung M, Tang E, Wu T, Luk Y, Au I, Liu X
NPJ Digit Med. 2025; 8(1):134.
PMID: 40025285
PMC: 11873034.
DOI: 10.1038/s41746-025-01528-y.
De Falco N, Agresti M, De Falco M, Sperlongano P, Moccia G, Luongo P
J Clin Med. 2025; 14(4).
PMID: 40004911
PMC: 11856133.
DOI: 10.3390/jcm14041382.
Mura C, Canu G, Lanzolla G, Cappellacci F, Medas F, Mariotti S
Cancers (Basel). 2025; 17(3).
PMID: 39941792
PMC: 11815924.
DOI: 10.3390/cancers17030422.
Hu A, Li Y, Wang Z, Tian J, Jiang K, Chen J
Endocrine. 2025; .
PMID: 39900746
DOI: 10.1007/s12020-025-04177-z.
Wang L, Cheng P, Zhu L, Tan H, Wei B, Li N
Sci Rep. 2024; 14(1):27585.
PMID: 39528685
PMC: 11554779.
DOI: 10.1038/s41598-024-78179-8.
Long-term effect of postoperative radioactive iodine therapy on parathyroid function in patients with differentiated thyroid cancer.
Avci Merdin F, Gokcay Canpolat A, Corapcioglu D, Soydal C, Sahin M
Ann Nucl Med. 2024; 39(3):278-284.
PMID: 39496869
DOI: 10.1007/s12149-024-01996-4.
Impact of location and size of minimal extrathyroidal extension on lymph node metastasis in papillary thyroid cancer: a retrospective analysis.
Zhan H, Hong Y, Zhang L, Huang K, Zheng M, Zhang F
Gland Surg. 2024; 13(9):1619-1627.
PMID: 39421047
PMC: 11480871.
DOI: 10.21037/gs-24-273.
Prognostic Implications of Maintaining the Target Thyroid-Stimulating Hormone Status Based on the 2015 American Thyroid Association Guidelines in Patients with Low-Risk Papillary Thyroid Carcinoma after Lobectomy: A 5-Year Landmark Analysis.
Jeon Y, Suh Y, Lim S
Cancers (Basel). 2024; 16(19).
PMID: 39409875
PMC: 11475063.
DOI: 10.3390/cancers16193253.
Explainable machine learning model for predicting paratracheal lymph node metastasis in cN0 papillary thyroid cancer.
Chun L, Wang D, He L, Li D, Fu Z, Xue S
Sci Rep. 2024; 14(1):22361.
PMID: 39333646
PMC: 11436978.
DOI: 10.1038/s41598-024-73837-3.
Occult Thyroid Carcinoma with Cervical Lymph Node Metastasis: A Rare Case Report.
Dabas S, Tiwari S, Ranjan R, Menon N, Gurung B, Shukla H
Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3566-3569.
PMID: 39130238
PMC: 11306887.
DOI: 10.1007/s12070-024-04614-x.
Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection.
Baran J, Bojarsky M, Halada S, Ricarte-Filho J, Isaza A, Franco A
Eur Thyroid J. 2024; 13(4).
PMID: 38984999
PMC: 11301529.
DOI: 10.1530/ETJ-23-0265.
[Severe hypereosinophilia as a paraneoplastic syndrome in a patient with differentiated thyroid cancer].
Videla E, De la Torre B, Ferrada P, Miller J, Torres E, Alvarez A
Rev Fac Cien Med Univ Nac Cordoba. 2024; 81(2):403-414.
PMID: 38941219
PMC: 11370870.
DOI: 10.31053/1853.0605.v81.n2.44472.
An Executive Summary of The Philippine Interim Clinical Practice Guidelines for the Diagnosis and Management of Well Differentiated Thyroid Cancer 2021.
Acta Med Philipp. 2024; 58(8):5-30.
PMID: 38812767
PMC: 11132293.
DOI: 10.47895/amp.vi0.6535.
Preoperative Prediction of Metastatic Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in cN0 Papillary Thyroid Carcinoma.
Shao J, Wang X, Yu H, Ding W, Xu B, Ma D
Cancer Manag Res. 2024; 16:421-429.
PMID: 38736588
PMC: 11086645.
DOI: 10.2147/CMAR.S454607.
The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q, Tan L, Tang X, Wang W, Su Y, Wu Z
Front Endocrinol (Lausanne). 2024; 15:1327766.
PMID: 38686207
PMC: 11056783.
DOI: 10.3389/fendo.2024.1327766.
The prognostic value of lymph node ratio for thyroid cancer: a meta-analysis.
Hu Y, Wang Z, Dong L, Zhang L, Xiuyang L
Front Oncol. 2024; 14:1333094.
PMID: 38384804
PMC: 10879587.
DOI: 10.3389/fonc.2024.1333094.
Prediction of cervical lymph node metastasis in differentiated thyroid cancer based on radiomics models.
Mu J, Cao Y, Zhong X, Diao W, Jia Z
Br J Radiol. 2024; 97(1155):526-534.
PMID: 38366237
PMC: 11027254.
DOI: 10.1093/bjr/tqae010.
The Impact of Total Tumor Diameter on Lymph Node Metastasis and Tumor Recurrence in Papillary Thyroid Carcinomas.
Can N, Bulbul B, Ozyilmaz F, Sut N, Ayyildiz Mercan M, Andac B
Diagnostics (Basel). 2024; 14(3).
PMID: 38337788
PMC: 10854897.
DOI: 10.3390/diagnostics14030272.
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero S, Gonzalez S, Juez J, Becerra D, Baldion A, Hakim J
Adv Ther. 2024; 41(2):792-805.
PMID: 38170436
DOI: 10.1007/s12325-023-02756-y.
Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes.
Simoes-Pereira J, Saramago A, Rodrigues R, Pojo M, Pires C, Horta M
Endocrine. 2023; 84(2):625-634.
PMID: 38102497
DOI: 10.1007/s12020-023-03633-y.
